• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)

    23.84 +0.66 (+2.85%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,626,576
    Open 23.75
    Bid (Size) 23.82 (3,000)
    Ask (Size) 23.94 (800)
    Prev. Close 23.18
    Today's Range 22.83 - 24.17
    52wk Range 14.62 - 26.25
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar ↗
    Trump is easing approval for psychedelic treatments for mental disorders. 
    Via The Motley Fool
    Topics Government
    News headline image
    Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
    From Definium Therapeutics, Inc.
    Via Business Wire

    Performance

    YTD
    +55.0%
    +55.0%
    1 Month
    +31.7%
    +31.7%
    3 Month
    +42.1%
    +42.1%
    6 Month
    +55.0%
    +55.0%
    1 Year
    +55.0%
    +55.0%

    More News

    Read More
    News headline image
    New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium (DFTX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics to Participate at Upcoming Investor Conferences
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Appoints Roger Adsett to Board of Directors
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    2026 Asset Growth: Why Federal Compliance Is the New Metric
    From Equity Insider
    Via GlobeNewswire

    Frequently Asked Questions

    Is Definium Therapeutics, Inc. - Common Shares publicly traded?
    Yes, Definium Therapeutics, Inc. - Common Shares is publicly traded.
    What exchange does Definium Therapeutics, Inc. - Common Shares trade on?
    Definium Therapeutics, Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Definium Therapeutics, Inc. - Common Shares?
    The ticker symbol for Definium Therapeutics, Inc. - Common Shares is DFTX on the Nasdaq Stock Market
    What is the current price of Definium Therapeutics, Inc. - Common Shares?
    The current price of Definium Therapeutics, Inc. - Common Shares is 23.84
    When was Definium Therapeutics, Inc. - Common Shares last traded?
    The last trade of Definium Therapeutics, Inc. - Common Shares was at 04/21/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.